IL2 and neoplasm: Upon reinfusion, CAR-T cells engage tumor surface antigens, triggering perforin/granzyme-mediated apoptosis and pro-inflammatory cytokine storms (e.g., IFN-γ, IL-2) that amplify bystander immune activation (96).